We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MRVT Miravant Med Tech: Infinity and Beyond?
An SI Board Since September 1997
Posts SubjectMarks Bans Symbol
67 6 0 MRVT
Emcee:  rgus Type:  Unmoderated
Robertson's Don Ellis initiates coverage on Miravant Med with a "BUY." Miravant has patented technology for photo-active cancer treatment. 1998 will step-up momentum with five or so trials, including a Ph III for breast cancer, of manifold indications. To boot, their treatment has a low side-effect profile. Earnings start to dribble in '00, and gush in '01. Now, let's get beyond this funny-mental fodder to the business at hand: making money. So...rough diamond or hype job?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
67Cyberonics (CYBX) trial received "insufficient stimulation," not MRVT.Marty Rubin-1/24/2002
66I haven't seen the report. However, in general, Phase II trials are intendeIan@SI-1/24/2002
65Ian, Do you believe the company which said Phase III were 50% underdosed? ThanMarty Rubin-1/24/2002
64Alan, Is there anything else promising for MRVT at this point? I was planning Marty Rubin-1/24/2002
63As SnET2 was the most advanced potential competitor from a Clinical Trial perspeIan@SI-1/15/2002
62I noticed the same thing, and I pretty much put up the press release to documentAlan Gallaspy-1/15/2002
61Alan, In the preceding post which was on Sept 12th, I asked, "In a slide Ian@SI-1/15/2002
60Miravant's eye treatment disappoints Stock plunges after firm says drug failAlan Gallaspy-1/14/2002
59In a slide comparing industry participants, I saw a one-liner saying that SnET2 Ian@SI-9/12/2001
58Monday June 4, 4:05 pm Eastern Time Press Release Miravant to Start Clinical Trbetone-6/5/2001
57Buying by a certain insider is the key to share price going higher. If I am wronstraight-->arrow-11/29/2000
56John, You're wildly optimistic on the high side, IMO. QLTI has had FDA apIan@SI-11/29/2000
55straight, Good luck. Actually, in six months this stock will either be $100 orJohn Lacelle-11/29/2000
54Buying 1500 shares today. Like insider buys and Co. is in a perfect group for prstraight-->arrow-11/29/2000
53Wednesday July 5, 7:10 pm Eastern Time Company Press Release Miravant Presents CIan@SI-7/5/2000
52 Some meaningful news to add to the torrent of posts recently. ;-) Miravant MeIan@SI-3/27/2000
51 LESS than 30 days from the J&J news..................Thomas J. Smith-9/23/1999
50 15 by wed. I think monday may be to soon for this 15 move.Thomas J. Smith-9/10/1999
49 15 by Monday............. Monday morning = 15 before resistance is met. Thomas J. Smith-9/9/1999
48 BUYOUT???? Not at liberty to say!Thomas J. Smith-9/9/1999
47 'Haven't looked at this one in some time. It's got plenty of workrgus-7/27/1999
46 all... after reading the investor packet from miravant medical technologies, isoozathelooza-7/14/1999
45 Anyone left? EOMMichael Anthony-7/7/1999
44 whats the rush to buy now. they will have no phase 3 data or catalyst for at leBioscoop-4/16/1999
43 Hello Tony, I am looking at June 7.5 calls or some September 10 calls. I am goiFD JR.-3/24/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):